Market Cap 28.26B
Revenue (ttm) 4.13B
Net Income (ttm) 1.01B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 24.36%
Debt to Equity Ratio 0.01
Volume 1,364,000
Avg Vol 695,180
Day's Range N/A - N/A
Shares Out 239.74M
Stochastic %K 65%
Beta 0.17
Analysts Strong Sell
Price Target $141.32

Latest News on BNTX

BioNTech Completes Acquisition of Biotheus

Feb 3, 2025, 6:45 AM EST - 19 days ago

BioNTech Completes Acquisition of Biotheus


US FDA lifts partial clinical hold on BioNTech cancer drug study

Dec 13, 2024, 4:12 PM EST - 2 months ago

US FDA lifts partial clinical hold on BioNTech cancer drug study


Why Is BioNTech Stock Trading Higher On Friday?

Dec 6, 2024, 1:14 PM EST - 2 months ago

Why Is BioNTech Stock Trading Higher On Friday?


BioNTech buys China's Biotheus to support oncology strategy

Nov 13, 2024, 6:52 AM EST - 3 months ago

BioNTech buys China's Biotheus to support oncology strategy


BioNTech to Acquire Biotheus to Boost Oncology Strategy

Nov 13, 2024, 6:45 AM EST - 3 months ago

BioNTech to Acquire Biotheus to Boost Oncology Strategy


BioNTech SE (BNTX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 1:05 PM EST - 3 months ago

BioNTech SE (BNTX) Q3 2024 Earnings Call Transcript


BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3

Nov 4, 2024, 9:41 AM EST - 3 months ago

BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3


BioNTech to Host Innovation Series R&D Day on November 14, 2024

Oct 31, 2024, 7:45 AM EDT - 4 months ago

BioNTech to Host Innovation Series R&D Day on November 14, 2024


BioNTech's Oncology Gamble: High Stakes, Big Potential

Oct 21, 2024, 8:00 AM EDT - 4 months ago

BioNTech's Oncology Gamble: High Stakes, Big Potential


BioNTech (BNTX) Presents at Innovation Series: AI Day

Oct 3, 2024, 12:20 PM EDT - 5 months ago

BioNTech (BNTX) Presents at Innovation Series: AI Day


Trade It or Fade It: The week's big biotech moves

Sep 13, 2024, 6:52 PM EDT - 5 months ago

Trade It or Fade It: The week's big biotech moves

MRK SMMT


BioNTech's Low Valuation, Many Shots On Goal Make It A Buy

Sep 11, 2024, 7:20 AM EDT - 5 months ago

BioNTech's Low Valuation, Many Shots On Goal Make It A Buy


Tempus Announces Real World Data Collaboration with BioNTech

Sep 4, 2024, 8:30 AM EDT - 6 months ago

Tempus Announces Real World Data Collaboration with BioNTech

TEM


BioNTech says FDA lifts partial hold on its cancer drug trial

Aug 19, 2024, 6:59 AM EDT - 6 months ago

BioNTech says FDA lifts partial hold on its cancer drug trial